Does UnitedHealthcare Cover Weight Loss Treatment in New York? A 2026 Guide

Last updated: August 28, 2026

UnitedHealthcare commercial plans in New York may cover some obesity evaluation, nutrition counseling, and weight-loss medications. Coverage typically depends on the medical policy, OptumRx formulary, prior authorization, BMI criteria, and whether the drug is for obesity versus another labeled use. New York mental-health parity (Timothy’s Law) does not require GLP-1 coverage. Always verify your own benefits before you book.

See if you may qualify for online weight-loss care through Klarity’s network of 2,000+ licensed providers. You can also browse conditions we treat.

TLDR

• UnitedHealthcare may cover medically necessary obesity visits and some anti-obesity drugs in New York. Benefits vary by employer PPO/HMO, NY State of Health, Medicare Advantage, Medicaid managed care, and Essential Plan products.
• Federal MHPAEA plus New York Insurance Law §§ 3221 and 4303 (Timothy’s Law) address mental health and substance use parity. They do not create a statewide mandate that commercial plans must cover Wegovy, Zepbound, or other GLP-1s for weight loss.
• New York Insurance Law §§ 3217-h and 4306-g (and Public Health Law § 4406-g) address telehealth on many fully insured plans. See the DFS telehealth FAQ and § 3217-h.
• Pharmacy benefits typically run through OptumRx. Check your plan’s Prescription Drug List (PDL). Prior authorization, step therapy, and quantity limits are common for GLP-1s. This is not the same as Cigna PA Policy IP0477, which governs stimulants, not obesity drugs.
• CVS/Caremark dropped Zepbound on many lists on July 1, 2025 and later reinstated it on October 1, 2026. OptumRx is a different PBM. Do not assume Caremark’s timeline applies to your UnitedHealthcare card.
• If you have Medicare Part D (including many Medicare Advantage pharmacy benefits), CMS’s Medicare GLP-1 Bridge starting July 1, 2026 may offer about $50 per month for certain Wegovy, Zepbound, and Foundayo products through December 31, 2027. That program sits outside ordinary commercial OptumRx rules. See CMS GLP-1 Bridge.
• HHS/DEA telemedicine flexibilities for prescribing many controlled medications currently run through December 31, 2026. Most first-line GLP-1s, Contrave, and orlistat are not scheduled. Phentermine and Qsymia are Schedule IV.
• Verify benefits on myuhc.com and OptumRx. For fully insured New York coverage disputes, DFS consumer assistance is (800) 342-3736. If you are in crisis, call or text 988.

Disclaimer: This article is educational. It is not a benefits determination, diagnosis, or guarantee of payment. Coverage varies by plan. Verify benefits with UnitedHealthcare and your clinician before you book.

Does UnitedHealthcare cover weight loss treatment in New York?

Often, some of it, with caveats. Evaluation visits, follow-up, and nutrition counseling for obesity may process as medical benefits on many UnitedHealthcare commercial plans when the visit is medically necessary and in network. Medication coverage is a separate pharmacy question. Copays, deductibles, BMI cutoffs, and whether Klarity (or any telehealth group) is in network still sit in your Summary of Benefits and Coverage, medical policy, and PDL.

Self-funded ERISA employer plans follow federal rules and the plan document more than New York Insurance Law. Medicare Advantage, Medicaid, and dual-eligible products follow CMS and state Medicaid rules, not Timothy’s Law in the same way. Always treat this page as education, not a coverage determination.

Check if your plan may cover a weight-loss visit.

Why Timothy’s Law does not decide GLP-1 coverage

Two layers matter in 2026 for mental health. They do not write your obesity formulary:

1. Federal MHPAEA. Group health plans and many individual plans that cover mental health or substance use disorder care generally cannot apply more restrictive financial requirements or treatment limitations than they apply to medical/surgical care in the same classification.
2. New York Insurance Law §§ 3221 and 4303, often discussed as Timothy’s Law. These statutes set long-standing mental health coverage mandates on many fully insured policies written in New York.

Obesity pharmacotherapy is typically a medical or pharmacy benefit, not a mental-health mandate. If UnitedHealthcare denies a GLP-1 as a plan exclusion or as not meeting BMI/comorbidity criteria, that is usually a medical-policy or formulary issue, not a Timothy’s Law claim. If the denial is about an eating-disorder or psychiatric visit billed as mental health, parity may apply. Keep those buckets separate when you appeal.

Related Klarity guides: Aetna NY Weight Loss, Cigna NY Weight Loss, and Humana NY Weight Loss.

Telehealth obesity visits in New York

New York Insurance Law §§ 3217-h and 4306-g generally require many fully insured plans to cover telehealth services that would be covered in person, when clinically appropriate. DFS publishes FAQs for insurers and providers at dfs.ny.gov. Employer self-funded plans may still reimburse video visits, but the statute may not bind them.

Klarity providers licensed in New York can evaluate weight-loss care by video when clinically appropriate. Same-day appointments are often available. Coverage still depends on whether the visit is billed in network and whether your plan treats telehealth at the same cost share as office care.

Federal controlled-substance telemedicine rules remain a separate overlay. HHS and DEA extended certain telemedicine flexibilities through December 31, 2026 (Federal Register extension; HHS announcement). That matters if a clinician considers phentermine or Qsymia (Schedule IV). It does not change coverage for non-scheduled GLP-1s, Contrave, or orlistat.

OptumRx, GLP-1s, and prior authorization

Most UnitedHealthcare pharmacy benefits use OptumRx. Members should open the current PDL on UnitedHealthcare prescription drug lists and the member tools on OptumRx. UnitedHealthcare notes that some medications need prior authorization: the prescriber explains medical need, then the plan decides how or if it will cover the drug (UHC pharmacy benefits).

Plans often:

• Place Wegovy, Zepbound, Saxenda, and similar agents on higher tiers with PA, step therapy, and quantity limits
• Require documented BMI, comorbidity, and lifestyle-program notes
• Cover metformin, Contrave, or orlistat on different tiers when medically necessary
• Exclude compounding or cash-pay “med spa” products

Do not mix PBM stories. CVS/Caremark (common on many Aetna cards) removed Zepbound from many lists on July 1, 2025 and later reinstated it on October 1, 2026. Cigna/Express Scripts historically did not drop Zepbound in that same way. OptumRx follows UnitedHealthcare’s own PDL for your group or individual product. Ask OptumRx for the exact drug name, dose, and PA criteria on your member ID.

Cigna PA Policy IP0477 (effective May 15, 2026) requires prior authorization for stimulants. It does not govern UnitedHealthcare obesity drugs. Stimulant PA is relevant only if you also use ADHD care; see UnitedHealthcare NY ADHD.

Klarity clinicians can help you understand what documentation a PA often needs. They cannot promise UnitedHealthcare will approve a drug.

Medicare GLP-1 Bridge (Part D / MA pharmacy, not a typical commercial PPO)

If you have Medicare Part D, including many UnitedHealthcare Medicare Advantage pharmacy benefits, CMS launched a Medicare GLP-1 Bridge starting July 1, 2026. Eligible beneficiaries may pay about $50 per month for certain products (Wegovy, Zepbound, Foundayo) through December 31, 2027. See the CMS press release, CMS GLP-1 Bridge page, and Medicare weight-loss drugs. This program does not replace a commercial UnitedHealthcare PPO or HMO formulary.

Medicaid and dual-eligible members follow New York Medicaid pharmacy rules, not this commercial guide and not Timothy’s Law as a GLP-1 mandate. Confirm the product on your ID card before you assume any of the above applies.

What a Klarity weight-loss visit in New York typically includes

Licensed providers in Klarity’s 2,000+ network can review BMI, medical history, current medications, and whether a prescription, nutrition plan, or referral is appropriate. Care is telehealth when clinically suitable. Medication is not automatic. Some patients start with lifestyle counseling or non-GLP-1 options when a GLP-1 is not appropriate or not on formulary.

Follow-up visits usually monitor side effects, dose, and whether the plan is helping. Your UnitedHealthcare plan may apply a specialist copay or require a referral on HMO-style products. If a medication is prescribed, OptumRx still decides coverage, copay, and pharmacy.

Verify whether online weight-loss care may fit your situation.

How to verify UnitedHealthcare benefits before you book

1. Log in to myuhc.com and open medical and pharmacy benefits. Confirm whether obesity treatment, nutrition counseling, and anti-obesity drugs are listed, excluded, or limited.
2. Call the member number on your ID card. Ask whether telehealth obesity visits with an out-of-state or multi-state group are in network for New York members.
3. On OptumRx, search Wegovy, Zepbound, Saxenda, Contrave, orlistat, phentermine, and Qsymia by NDC or brand/generic. Note tier, PA, step therapy, and quantity limits.
4. Ask for the medical policy number for “obesity,” “weight management,” or “GLP-1 receptor agonist.” Save the PDF.
5. If you have Medicare Advantage or Part D, ask whether the Medicare GLP-1 Bridge applies to your contract, separate from the commercial PDL.
6. If you have NY Medicaid or Essential Plan, ask the plan’s Medicaid/Essential pharmacy desk. Do not use commercial OptumRx assumptions.

Appeals and New York DFS

If UnitedHealthcare or OptumRx denies a visit or PA, use the plan’s internal appeal first. For many fully insured New York policies, the New York Department of Financial Services consumer line is (800) 342-3736. External appeal rights depend on the plan type. Self-funded ERISA plans usually go through the employer and federal process, not DFS, in the same way. Medicare Advantage denials follow CMS appeal timelines, not Timothy’s Law.

Related UnitedHealthcare and New York guides

• Does UnitedHealthcare cover ADHD treatment in New York?
• Does UnitedHealthcare cover anxiety treatment in New York?
• Does UnitedHealthcare cover depression treatment in New York?
• Does Cigna cover weight loss treatment in New York?
• Does Aetna cover weight loss treatment in New York?
• Does Humana cover weight loss treatment in New York?

Disclaimer

This article is educational, not a benefits determination. Coverage varies by plan, employer, formulary year, and medical necessity. Confirm benefits with UnitedHealthcare/OptumRx before you start care. If you are in crisis, call or text 988.

Check if your plan may cover this kind of visit · See conditions